TIAA CREF INVESTMENT MANAGEMENT LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2015$57,000
-72.6%
20,798
-66.5%
0.00%
Q1 2015$208,000
-3.3%
62,0370.0%0.00%
Q4 2014$215,000
-33.8%
62,037
-3.9%
0.00%
Q3 2014$325,000
-64.4%
64,584
-2.4%
0.00%
-100.0%
Q2 2014$914,00066,1950.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 89,240$255,0000.09%
BT Wealth Management LLC 57,009$163,0000.08%
HighVista Strategies LLC 30,200$86,0000.06%
D.A. DAVIDSON & CO. 840,948$2,405,0000.04%
Iron Gate Global Advisors LLC 17,090$49,0000.03%
Advisor Group, Inc. 799,846$2,287,0000.02%
Virtu Financial LLC 54,738$157,0000.02%
JOYN Advisors, Inc. 12,796$37,0000.01%
Vivaldi Capital Management LP 10,668$31,0000.01%
Ameritas Investment Company, LLC 10,782$31,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders